Dr Rischin on the Efficacy of Adjuvant Cemiplimab in High-Risk CSCC | OncLive
Dr Rischin on the Efficacy of Adjuvant Cemiplimab in High-Risk CSCC | OncLive
7 months ago
onclive.com
Long-Term Efficacy of Cemiplimab Encourages Flexibility When Treating NSCLC: Ana Baramidze, MD | AJMC
Long-Term Efficacy of Cemiplimab Encourages Flexibility When Treating NSCLC: Ana Baramidze, MD | AJMC
8 months ago
ajmc.com
CSCC Treatment Options: Cemiplimab and Pembrolizumab | OncLive
CSCC Treatment Options: Cemiplimab and Pembrolizumab | OncLive
Apr 19, 2023
onclive.com
Dr Neil Gross: Cemiplimab Has Great Potential in cSCC | AJMC
Dr Neil Gross: Cemiplimab Has Great Potential in cSCC | AJMC
Dec 5, 2022
ajmc.com
Adjuvant Cemiplimab: New Standard for High-Risk CSCC Recurrence | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
2:05
Adjuvant Cemiplimab: New Standard for High-Risk CSCC Recurrence | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
8 months ago
targetedonc.com
ESMO 2025 Highlights: Melanoma Neoadjuvant Approaches, Vaccine, IO Duration, Cemiplimab for cSCC and STAMP in Merkel Cell Carcinoma
ESMO 2025 Highlights: Melanoma Neoadjuvant Approaches, Vaccine, IO Duration, Cemiplimab for cSCC and STAMP in Merkel Cell Carcinoma
5 months ago
vumedi.com
Phio Pharmaceuticals Corp. recently participated in the VIC Life Sciences Investor Forum - Clip 4
1:27
Phio Pharmaceuticals Corp. recently participated in the VIC Life Sciences Investor Forum - Clip 4
50 views3 weeks ago
YouTubeB2i Digital, Inc.
0:59
Cemiplimab Data Achieve “Significant Milestone” in NSCLC
31 views1 month ago
YouTubeCancerNetwork
0:41
Dr Saurav Dhawan on Instagram: "Cemiplimab for locally advanced or metastatic cSCC #oncology #cancer #chemotherapy #medicine #radiotherapy"
485 views3 months ago
Instagramoncolizumab
Cemiplimab Exhibits Long-Term Clinical Benefit in Advanced NSCLC Trial | CancerNetwork
1 month ago
cancernetwork.com
1:21
Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a B2i Digital Featured Company, recently presented at the Virtual Investor Conferences Life Sciences Investor Forum. In the clip below, President and CEO… | David Shapiro
1 month ago
linkedin.com
Dr. Dustin Portela | Skincare & Health Expert | 🚨 Big news for high-risk skin cancer patients! The FDA just approved Cemiplimab (Libtayo) for use before metastasis in patients with... | Instagram
7 months ago
Instagram
3:10
Current Strategies for Managing CMV Infection
8.1K viewsApr 5, 2018
YouTubeOncLive
0:52
Benefit With Cemiplimab in Patients With mCSCC
491 viewsDec 13, 2018
YouTubeTargeted Oncology
2:40
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Oct 25, 2023
Vimeoecancer
7:51
Carcinoma squamocellulare avanzato, conferme di efficacia per l’immunoterapia con cemiplimab
2.4K viewsJun 3, 2020
YouTubePharmaStarTV
7:34
Cemiplimab Post-Treatment Considerations
799 viewsFeb 25, 2019
YouTubeOncLive
7:22
Advanced/Metastatic cSCC Treatment Options
1.6K viewsFeb 5, 2019
YouTubeOncLive
7:01
Cemiplimab Phase I Trial
1K viewsFeb 15, 2019
YouTubeOncLive
4:51
Advanced CSCC: The New Systemic Therapy
535 viewsOct 31, 2018
YouTubeTargeted Oncology
5:54
Research Findings in CMV Infection
806 viewsApr 5, 2018
YouTubeOncLive
4:13
Cemiplimab in Managing Advanced cSCC
940 viewsJun 4, 2019
YouTubeTargeted Oncology
14:32
Systemic Therapy For Nonmelanoma Skin Cancer and Emerging Research
2.5K viewsOct 27, 2023
YouTubeAIM at Skin Cancer Foundation
12:06
Systemic Therapies for CSCC and BCC
129 viewsAug 20, 2024
YouTubeAIM at Skin Cancer Foundation
55:11
Cutaneous Squamous Cell Carcinoma: Immunotherapy Updates with Dr. Butler, MD
3.9K viewsNov 18, 2019
YouTubeMelanoma Canada
1:24
Dr Patel: Considerations for Adjuvant Cemiplimab #TargetedTreatmentTips
154 views6 months ago
YouTubeTargeted Oncology
48:25
The Immunotherapy Story Continues for CSCC
199 views6 months ago
YouTubePeerView Oncology
1:05
Promise of adjuvant immunotherapy in cutaneous SCC
83 viewsApr 3, 2025
YouTubeVJOncology
1:04
Evaluating fianlimab and cemiplimab in PD-L1+ recurrent/metastatic HNSCC
136 views11 months ago
YouTubeVJOncology
4:12
What Are The Latest Immunotherapy Breakthroughs For SCC? - Lung Cancer Support Hub
12 views6 months ago
YouTubeLung Cancer Support Hub
See more
Static thumbnail place holder